Desogestrel Versus GnRH Antagonist in IVF/ICSI
Launched by CASA DI CURA PRIVATA VILLA MAFALDA · Jan 27, 2021
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
Study design A prospective controlled randomized clinical trial (RCT) will be conducted to assess the non inferiority of Desogestrel (75 mcg) versus a flexible GnRH antagonist protocol with ganirelix (0.25 mg/day) in ovarian stimulation cycles.All partecipants will provide informed consent after counselling for infertility treatments and routine IVF procedures.
This will be a prospective non-inferiority trial. Given the possibility of dropouts, the study will be designed to include a total of 165 patients Patients will be recruited consecutively and allocated to one of the two groups in al...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • regular menstrual cycles over the previous 3-month period (25 - 35 days in duration)
- • basal serum FSH concentration of no more than 10 IU/L
- Exclusion Criteria:
- • documented ovarian failure, including basal FSH above 10 IU/L or no antral follicles by ultrasound examination
- • diagnosis of polycystic ovarian syndrome
- • any controindication to ovarian stimulation treatment.
About Casa Di Cura Privata Villa Mafalda
Casa di Cura Privata Villa Mafalda is a renowned private healthcare facility committed to delivering high-quality medical services and innovative treatments. With a focus on patient-centered care, the institution combines advanced medical technology with a dedicated team of experienced professionals. Villa Mafalda is actively involved in clinical research, aiming to enhance therapeutic options and improve patient outcomes. The facility prioritizes safety and ethical standards in all its trials, fostering collaborations with leading healthcare organizations to contribute to medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials